COGZF (Cogstate) Short Interest


COGZF Cogstate Ltd COGZF
90 GF Score
Price $1.89
GF Value $1.57
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cogstate Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

COGZF vs VEEV, BTSG, TEM: Short Interest Comparison

For the Health Information Services subindustry, Cogstate's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cogstate Short Interest vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cogstate's Short Interest distribution charts can be found below:

* The bar in red indicates where Cogstate's Short Interest falls into.


COGZF
90GF Score
Cogstate Ltd COGZF
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cogstate (COGZF) Overvalued in 2026?

Based on GuruFocus' analysis, Cogstate stock appears to be overvalued. The current stock price of $1.89 is trading 20.4% above its estimated GF Value™ of $1.57. GuruFocus considers Cogstate to be Modestly Overvalued.

Key valuation signals for COGZF:

  • Short Interest:
  • GF Value™: $1.57 vs. price of $1.89 (20.4% above fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the COGZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cogstate Business Description

Other Exchanges C4B:GermanyCGS:Australia
Address 367 Collins Street, Level 32, Melbourne, VIC, AUS, 3000
Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
90GF Score

Get the complete analysis for COGZF

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.89
Price
$1.57
GF Value